Criterion Capital Advisors, LLC Novartis Ag Transaction History
Criterion Capital Advisors, LLC
- $159 Billion
- Q4 2024
A detailed history of Criterion Capital Advisors, LLC transactions in Novartis Ag stock. As of the latest transaction made, Criterion Capital Advisors, LLC holds 45 shares of NVS stock, worth $4,907. This represents 0.0% of its overall portfolio holdings.
Number of Shares
45
Previous 45
-0.0%
Holding current value
$4,907
Previous $4.79 Million
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding NVS
# of Institutions
1,479Shares Held
134MCall Options Held
1.31MPut Options Held
1.56M-
Dodge & Cox San Francisco, CA12.2MShares$1.33 Billion0.74% of portfolio
-
Primecap Management CO Pasadena, CA11MShares$1.2 Billion0.85% of portfolio
-
Dimensional Fund Advisors LP Austin, TX8.18MShares$893 Million0.2% of portfolio
-
Morgan Stanley New York, NY6.87MShares$749 Million0.05% of portfolio
-
Loomis Sayles & CO L P5.58MShares$608 Million0.68% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $235B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...